Celgene’s Abraxane flops in pivotal pancreatic cancer study
Source: https://ift.tt/2JbA0S3
The news closely followed that of the FDA approving the first immunotherapy drug for cancer, Roche’s Tecentriq, in combination with Abraxane.
Source: https://ift.tt/2JbA0S3
0 Comments